Arsanis logo

Arsanis

Leading the fight against infectious diseases with advanced monoclonal antibody therapies.

11-50 employees · est. 2010

VS
Helmholtz Centre for Infection Research logo

Helmholtz Centre for Infection Research

Our research leads to new strategies in the fight against infectious diseases.

458 employees · est. 1965 · Brunswick, Germany

Helmholtz Centre for Infection Research is the older company (2010 vs 1965); Helmholtz Centre for Infection Research is the larger of the two.

Side-by-Side Comparison

Arsanis Helmholtz Centre for Infection Research
Founded
2010 1965 older
Headquarters
Not tracked yet Brunswick, Germany
Employees
11-50 458 larger
Industry
Biotechnology, Health Care, Life Sciences Messaging
Funding Stage
Post Ipo Equity Grant
Total Funding
$120.26M $1.33M
Funding Rounds
9 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceuticals, Monoclonal Antibodies, Infectious Diseases, Clinical-stage, Immunotherapies, MAb Discovery, Staphylococcus Aureus, Phase 2 Clinical Trial, Preclinical Pipeline, Antibacterial Therapies, Viral Pathogens, Respiratory Syncytial Virus, Waltham, Massachusetts, Vienna, Austria, Pathogenesis Of Infection Infection Research, Drug Development, Vaccine Development, Pathogen Mechanisms, Medical Applications, Diagnostic Tools, Immunology, Epidemiology
Website
arsanis.com helmholtz-hzi.de
Arsanis logo

About Arsanis

Arsanis is a clinical-stage biopharmaceutical company founded in 2010 that focuses on developing monoclonal antibody (mAb) immunotherapies to combat serious infectious diseases. The company's lead clinical program, ASN100, targets Staphylococcus aureus infections and is currently in Phase 2 clinical...

Helmholtz Centre for Infection Research logo

About Helmholtz Centre for Infection Research

Helmholtz Centre for Infection Research (HCIR) is a research institution based in Germany with a mission to develop new strategies to combat infectious diseases. Since its establishment in 1965, HCIR has been conducting in-depth research on the mechanisms of infectious diseases and their defense. Th...

We will tell you when either one moves

BounceWatch watches Arsanis and Helmholtz Centre for Infection Research for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Arsanis and Helmholtz Centre for I... — by email.

Frequently Asked Questions

Arsanis — Leading the fight against infectious diseases with advanced monoclonal antibody therapies.. Helmholtz Centre for Infection Research — Our research leads to new strategies in the fight against infectious diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Arsanis has raised $120.26M while Helmholtz Centre for Infection Research has raised $1.33M.
Arsanis and Helmholtz Centre for Infection Research operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Arsanis with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Arsanis on 12 Sep 2024, and Helmholtz Centre for Infection Research on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes